$4.17
-0.07-1.54%
At close: -
$3.84
-0.33-7.80%
After Hours: Oct 22, 4:16 PM EDT
Comments
Loading...
CollPlant Biotechnologies (NASDAQ:CLGN) Stock, Earnings Estimates, EPS, And Revenue
CollPlant Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 27
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$400K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$689K
Analyze the earnings history of CollPlant Biotechnologies using advanced sorting and filters.
Data brought to you by Benzinga APIs
CollPlant Biotechnologies (CLGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-20 | $-0.33 | $-0.35 | 5.71 % |
| Mar 2024 | 2024-05-29 | $-0.35 | $-0.35 | 0.00 % |
| Mar 2024 | 2024-04-04 | $-0.35 | $-0.07 | -400.0 % |
| Sep 2023 | 2023-11-29 | $-0.35 | $-0.13 | -169.2 % |
CollPlant Biotechnologies (CLGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-20 | $249.00K | $700.00K | -64.4 % |
| Mar 2024 | 2024-05-29 | $98.00K | $600.00K | -83.7 % |
| Mar 2024 | 2024-04-04 | $299.00K | $8.56M | -96.5 % |
| Sep 2023 | 2023-11-29 | $43.00K | $3.50M | -98.8 % |
FAQ
When is CollPlant Biotechnologies (NASDAQ:CLGN) reporting earnings?
CollPlant Biotechnologies (CLGN) is scheduled to report earnings on November 27, 2024. The last reported earnings were for reported on August 20, 2024 for Q2.
What were the latest earnings per share (EPS) for CollPlant Biotechnologies (NASDAQ:CLGN)?
The Actual EPS was $-0.33, which beat the estimate of $-0.35.
What were CollPlant Biotechnologies’s (NASDAQ:CLGN) revenues?
The Actual Revenue was $249K, which missed the estimate of $700K.
Browse earnings estimates, EPS, and revenue on all stocks.